IC
PRME icon

IEQ Capital’s Prime Medicine PRME Stock Holding History

IEQ Capital’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$258K Buy
74,013
+36,877
+99% +$140K ﹤0.01% 1585
2025
Q4 		$129K Buy
37,136
+469
+1% +$2.09K ﹤0.01% 1743
2025
Q3 		$203K Buy
36,667
+837
+2% +$3.4K ﹤0.01% 1681
2025
Q2 		$88.5K Buy
35,830
+948
+3% +$1.46K ﹤0.01% 1726
2025
Q1 		$69.4K Buy
+34,882
New +$89K ﹤0.01% 1526

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

IEQ Capital's PRME Position: Q1 2026 in Review

IEQ Capital increased its Prime Medicine (PRME) stake by 99% in Q1 2026, buying an estimated $140K and bringing the position to 74,013 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

IEQ Capital first reported a position in PRME in Q1 2025 and has held it in 5 quarters since. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • IEQ Capital held 74,013 shares of Prime Medicine worth $258K as of Q1 2026.
  • IEQ Capital bought 36,877 Prime Medicine shares in Q1 2026, an estimated $140K.
  • Prime Medicine made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1585 holding.
  • IEQ Capital first reported a position in Prime Medicine in Q1 2025 and has held it in 5 quarters since.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.